“The positive outlook revision is based on DRMC’s consistently robust operating margins and growing unrestricted reserves,” said S&P analyst Patrick Zagar. “Moreover, the hospital fully retired its variable rate series 2006 [certificates of participation] in March 2016, considerably improving debt metrics and debt service coverage.”
S&P also affirmed the “BBB-” rating on DRMC’s $27.7 million of series 2012 certificates of participation.
More articles on healthcare finance:
Craneware, OhioHealth to present on pharmacy revenue integrity HFMA’s Annual National Institute
NJ owes counties $37M in Medicaid repayments
Moody’s affirms Flagler Hospital’s ‘A3’ rating
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
